Scientific Program

Conference Series Ltd invites all the participants across the globe to attend 4th International Conference on Clinical and Counseling Psychology Tokyo, Japan.

Day 1 :

Keynote Forum

Sunita Rai

Clinical Director at Holistic Ed-Venture; Singapore

Keynote: Integrated Wellbeing Model (IWM) for Psychotherapy and Coaching

Time : 09:00-09:40

OMICS International Clinical Psychologists 2019 International Conference Keynote Speaker Sunita Rai photo
Biography:

Sunita has over 22 years of experience in local and regional marketing; corporate training and staff development; psychotherapy and counselling; education; mindfulness; and wellbeing amongst others. She is a skilled facilitator, coach, psychotherapist and lecturer. She has developed Integrated Wellbeing Model (IWM) for psychotherapists and co-developed a unique model of leadership called Positive Performance Leadership (PPL) for leaders. She is currently writing a book on wellbeing and happiness. She is the Clinical Director at Holistic Ed-Venture, Director and Mindfulness Psychologist at Centre for Mindfulness and Director and Wellbeing Strategist at Positive Performance Consulting. She has a Doctor of Psychology, Master of Social Science (Counselling), Bachelor of Arts in Psychology and Bachelor of Business in Business Administration with Merit (Marketing Major) amongst others.

Abstract:

Integrated Wellbeing Model (IWM) focuses on Five Selves of wellbeing by catering to all levels of human experience and by redefining the roles of a psychotherapist to focus on holistic wellbeing of clients. The Five Selves are: Eudaimonic, Intellectual, Emotional, Physical and Spatial. Wellbeing can be enhanced by analyzing, redefining and redesigning our lives in each of the Five Selves individually or collectively.

OMICS International Clinical Psychologists 2019 International Conference Keynote Speaker Joseph Rosado photo
Biography:

After spending several years in central Florida working as an orderly, then an EMT/Paramedic and Heart Cath Lab technician, Dr. Rosado realized his passion for the medical profession. He started chiropractic school at Life College in Marietta, GA where he graduated cum laude with a BS degree in Clinical Nutrition and a doctor of chiropractic degree. After practicing for several years, he went on to Universidad Central del Este, in San Pedro de Macoris where in 2001 he graduated summa cum laude with his medical degree. In 2005 he completed his MBA in Health Care Management from University of Phoenix, and graduated magna cum laude. He has worked as a physician, clinic and hospital director, director of the communicable disease division/epidemiology and immunization departments. Presently, Dr. Rosado is the Medical Director of a medical cannabis clinic and volunteers once a month at a community clinic. He was and is on the bureau of speakers for political campaigns, cannabis advocacy and medical cannabis dispensaries. To date, he has worked with over 2,000 patients, which include infants, toddlers, children, adolescents, adults and geriatrics for the evaluation, recommendation and management of medical cannabis.

Abstract:

Posttraumatic stress disorder (PTSD) is a prevalent, chronic, and disabling anxiety disorder that may develop following exposure to a traumatic event. Although the use of Medical Cannabis for the treatment of physical and psychological disorders is controversial, medical marijuana is currently legal in Canada, 30 states in the United States and a handful of countries in South America. Studies published in Molecular Psychiatry and Science Daily showed that treatment using particular compounds found in marijuana may benefit those with PTSD, and that “plant-derived cannabinoids [psychoactive chemicals] such as marijuana may possess some benefits in individuals with PTSD by helping relieve haunting nightmares and other symptoms of PTSD” and As a result of taking medical marijuana, participants reported a decrease in re-experiencing the trauma, less avoidance of situations that reminded them of the trauma, and a decline in hyper-arousal, respectively. There’s also convincing evidence from multiple studies for reduced endocannabinoid availability in PTSD, i.e., reduced levels of the endocannabinoid anandamide and compensatory increase of CB1 receptor availability in PTSD, and an association between increased CB1 receptor availability in the amygdala and abnormal threat processing, as well as increased severity of hyperarousal, but not dysphoric symptomatology, in trauma survivors. Other studies suggest that Medical Cannabis therapy, as an adjunct to a traditional analgesic therapy, can be an efficacious tool to make more effective the management of chronic pain and its consequences on functional and psychological dimensions. The patient in this case study had been treated for over 20 years with multiple opiates, SSRIs, SNRIs, typical and atypical antipsychotics, antiepileptics, etc. to manage her conditions; I will demonstrate how in less than three months, she was off of all of the pharmacological treatments and solely using Medical Cannabis is having a quality of life she had not experienced since before her adolescence.